Profile: Acologix, Inc. is a biopharmaceutical company focused on the identification & development of therapies for the treatment of osteorenal diseases, including the ones related to hard tissues such as bone, cartilage & teeth, as well as the kidney and associated organs. We offer AC-820, which is a small synthetic molecule that is a highly selective kappa opioid receptor agonist showing a potent anti-itching activity. Our AC-100 is a novel hard tissue growth factor derived from a large molecule, which is primarily produced by human bone and dental cells.